1. Is androgen deprivation therapy for prostate cancer associated with cardiovascular disease? A meta‐analysis and systematic review
   Zhen Liang et al, 2020, Andrology CrossRef
2. Association between duration of gonadotrophin‐releasing hormone agonist use and cardiovascular risks: A population‐based competing‐risk analysis
   Jeffrey S. K. Chan et al, 2022, The Prostate CrossRef